Covidien Ltd. (NYSE:COV)
| CAPS Rating |
|
|---|---|
| Open | $51.72 |
| Previous Close | $52.10 |
| Daily Range | $51.22 - $51.83 |
| 52-Week Range | $41.35 - $57.65 |
| Market Cap | $25.51B |
| P/E Ratio | 12.20 |
| Dividend (Yield) | 0.90 (1.40%) |
| Volume | 2,732,791 |
| Average Daily Volume | 0 |
COV
VS S&P 500 (SPY)
How do you think COV will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
COV Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
COV News and Commentary
- Cardica's Losses Trim in 2Q - Analyst Blog – NASDAQ
- Earnings Scorecard: Covidien - Analyst Blog – NASDAQ
- Covidien's Solitaire Ok'd for Trial - Analyst Blog – NASDAQ
- Covidien Beats Estimates Yet Again – The Motley Fool
- Covidien EPS Tops, Snips Sales View - Analyst Blog – NASDAQ
- Covidien 1Q Net Up 16% On Medical Device Sales, Stronger Margins – SmartMoney
- Earnings Preview: Covidien - Analyst Blog – NASDAQ
- US STOCK FUTURES: HOT STOCKS TO WATCH – SmartMoney
- Covidien CEO Almeida To Add Chairman Title – SmartMoney
- 2nd UPDATE: Covidien Unveils Expanded Recall Of Brain Sensors – SmartMoney
- UPDATE: Covidien Unveils Expanded Recall Of Brain Sensors – SmartMoney
- US STOCK FUTURES: HOT STOCKS TO WATCH – SmartMoney
- Covidien Unveils Expanded Recall of BIS Bilateral Sensors – SmartMoney
- Covidien Recalls Duet TRS - Analyst Blog – NASDAQ
- Cardica Suspends Enrollment - Analyst Blog – NASDAQ
- Covidien Wraps up BARRX Buy - Analyst Blog – NASDAQ
- Profit From These Special Situations – The Motley Fool
- This Just In: Upgrades and Downgrades – The Motley Fool
- Don't Get Too Worked Up Over Masimo's Latest Numbers – The Motley Fool
- 3 Industries With a Big Upside in 2012 – The Motley Fool
RSS Headlines
Fool UK
